Mass Spectrometry for the Evaluation of Cardiovascular Diseases Based on Proteomics and Lipidomics.

Mass Spectrometry for the Evaluation of Cardiovascular Diseases Based on Proteomics and Lipidomics. A. Thomas*, S. Lenglet, P. Chaurand*, J. Deglon, P. Mangin, F. Mach, S. Steffens, J-L. Wolfender and C. Staub. Thrombosis & Haemostasis, Vol. 106, 20-33 (2011). 

This content is not available in the selected language.

This content has been updated on 1 February 2023 at 1 h 35 min.